Key Players
Competitive Landscape
Competition in desiccant closures comes from four business models that enter pharmaceutical specifications at different points. Sanner and Colorcon sell integrated moisture-control formats while Aptar CSP Technologies supplies active-material platforms for pharmaceutical packaging programs. Larger container groups compete through bottle compatibility and validation support instead of desiccant specialization alone.
The competitive shift became visible in July 2025 as packaging groups expanded regional manufacturing and adjacent containment support. Colorcon opened a 200,000-square-foot Malaysia facility that month to strengthen pharmaceutical production support for Asia-Pacific customers. West opened a 165,000-square-foot Dublin expansion in March 2026 for high-volume injectable contract services and packaging support. Neither announcement directly expands desiccant-closure production because both investments serve broader pharmaceutical production and development platforms. Their commercial relevance is the wider validation support now available beside specialized closure technology during qualification.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| In July 2026, Sanner established a Belfast base for regional drug-delivery and medical-device engineering support. | Pharmaceutical programs need local engineering access once packaging or delivery changes enter formal qualification programs in regional development centers. | Specialists are placing technical teams closer to drug-development clusters instead of relying only on distant production sites. | Local support can shorten design reviews and troubleshooting for moisture-sensitive packaging programs entering regional trials. |
| In July 2025, Aptar acquired Mod3 clinical-trial materials manufacturing capabilities for pharmaceutical development programs and supply. | Drug developers need packaging support earlier while clinical materials and container choices are still being defined. | Active-material companies are extending upstream into clinical supply services that influence packaging choices before commercial specifications become fixed. | Earlier program access gives Aptar more chances to specify protective packaging before commercial container formats become fixed. |
| In June 2026, Amcor expanded healthcare packaging production at its Sira facility in India for regional pharmaceutical customers. | Regional pharmaceutical producers need shorter supply routes for high-performance healthcare packaging and drug-delivery components at scale. | Large packaging groups are adding healthcare capacity near growing South Asian pharmaceutical manufacturing bases to shorten regional supply routes. | Regional production can support faster samples and scale-up for healthcare packaging programs that later require qualified closure interfaces. |
Colorcon, ALPLApharma, Gerresheimer, West Pharmaceutical Services and SCHOTT Pharma compete outside the development table through broader pharmaceutical manufacturing or containment positions.
Source: Future Market Insights, Desiccant Closures and Pharmaceutical Caps and Closures Market Reports, 2026-2036.
Together the mapped companies cover integrated desiccant formats plus active-material protection and regulated container interfaces used during pharmaceutical qualification.
Who leads the desiccant closures market?
Sanner and Colorcon hold the clearest direct positions because both document integrated desiccant packaging for oral solid-dose applications.
Which suppliers have documented qualification or quality approvals?
Sanner documents certified child-resistant performance while West supplies validated closure formats and ALPLA adds clean-room closure manufacturing through its KM Packaging agreement.
Which companies provide oral-solid moisture-control products?
Sanner, Colorcon and Aptar CSP Technologies provide the strongest documented routes to active moisture protection for solid-dose pharmaceutical packaging.
Which suppliers serve Europe and North America?
Sanner, Amcor, West Pharmaceutical Services and Gerresheimer maintain manufacturing or technical coverage in European and North American pharmaceutical packaging.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| Sanner | Direct desiccant-packaging specialist with integrated moisture-management closures for pharmaceutical solid-dose formats. | In July 2026, Sanner established a Belfast base to expand drug-delivery and medical-device engineering support in the region. |
| Colorcon | Controlled-atmosphere packaging company with integrated desiccant closure capability for pharmaceutical and nutraceutical bottles. | In July 2025, Colorcon opened a 200,000-square-foot Malaysia manufacturing facility for pharmaceutical film-coating production and regional supply. |
| Aptar CSP Technologies | Active-material science platform with packaging-delivered protection in bottle and other pharmaceutical formats. | In July 2025, Aptar acquired Mod3 clinical-trial materials manufacturing capabilities to broaden pharmaceutical development services. |
| ALPLApharma | Broader pharmaceutical packaging group with bottle and closure manufacturing at the edge of direct desiccant scope. | In June 2025, ALPLA agreed to acquire KM Packaging and six closure-production sites in Europe and the United States. |
| Gerresheimer | Global drug-containment group with closure options and drug-delivery platforms outside direct desiccant specialization. | In March 2026, Gerresheimer introduced Gx InMonit as an add-on support platform for autoinjector-based home therapies. |
| West Pharmaceutical Services | Validated pharmaceutical closure specialist focused mainly on injectable containment instead of oral desiccant closures. | In March 2026, West opened a 165,000-square-foot Dublin expansion for high-volume injectable contract services and packaging support. |
| Amcor | Diversified healthcare packaging company with a containers-and-closures platform adjacent to direct desiccant specialization. | In June 2026, Amcor expanded healthcare packaging production at its Sira facility in India through a multi-million-dollar investment. |
| SCHOTT Pharma | Drug-containment specialist at the edge of scope because its current portfolio centers on vials and cartridges. | In May 2025, SCHOTT Pharma launched a sterile 1.5 ml ready-to-use cartridge for pharmaceutical fill-and-finish operations. |
Research Methodology
The companies mapped here illustrate the market structure instead of providing an exhaustive ranking of every active closure manufacturer. Inclusion requires current verifiable evidence that a company supplies desiccant closures or directly adjacent pharmaceutical container-closure platforms within the defined market scope. Evidence comes from regulatory approvals, third-party certifications, company announcements, product documentation and relevant public filings. Capabilities are attributed to the stated desiccant-closure platform or pharmaceutical closure service line rather than generalised across broader corporate portfolios. FMI treats market-share estimates as proprietary assessments for the stated 2026-2036 forecast period in this title.
